ULTRALIFE CORP — Director's Dealing 2025

Nov 26, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2025-11-24

Reporting Person: Robert W. Shaw (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-24	Common Stock; $.10 par value	P	1750	$5.67	Acquired	71000	Direct